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Introduction
Neurofibromatosis 1 (NF1) is a common, inherited disease 
associated with benign and malignant peripheral nerve sheath 
tumours.1 The complications of NF1 are variable, unpredicta-
ble and widespread, and cognitive impairment is common.1 
Challenges with functional tasks such as walking, balance or 
using the hands are common in NF1.2 They may arise from 
tumours causing pressure on peripheral nerves or the spinal 
cord, central nervous system tumours or skeletal abnormalities. 
The relationship between objective performance and subjec-
tive experience is also important. Functional challenges may 
be amenable to medical, surgical or physical interventions and 
there is a need for robust functional outcome measures in this 
patient group to assess treatment efficacy. To the best of our 
knowledge, there has been no systematic evaluation of func-
tional, motor outcome measures in adults with this disease.
An essential requirement of robust outcome measure-
ments is that they are reliable.3 Reliability is defined as ‘the 
degree to which measurement is free from measurement 
error’.4 It is important to evaluate properties such as 
Reliability of functional outcome measures  
in adults with neurofibromatosis 1
Rebecca L Mullin1,2 , John F Golding3, Rebecca Smith1,2,  
Victoria Williams1, Mary Thomas1 and Rosalie E Ferner1 
Abstract
Objectives: To determine intra-rater and inter-rater reliability of functional outcome measures in adults with 
neurofibromatosis 1 and to ascertain how closely objective and subjective measures align.
Methods: A total of 49 ambulant adults with neurofibromatosis 1 aged 16 years and over were included in this observational 
study: median age 31 years (range: 16–66 years), 29 females, 20 males. Participants were video-recorded or photographed 
performing four functional outcome measures. Four raters from the neurofibromatosis centre multi-disciplinary team 
independently scored the measures to determine inter-rater reliability. One rater scored the measures a second time on 
a separate occasion to determine intra-rater reliability. The measures evaluated were the functional reach, timed up and 
go, 10 m walk and a modified nine-hole peg tests. Participants also completed a disease-specific quality-of-life questionnaire.
Results: Inter-rater reliability and intra-rater reliability scores (intra-class coefficient) were similar for each outcome 
measure. Excellent rater agreement (intra-class coefficient, r ⩾ 0.9) was found for the functional reach, timed up and go 
and the 10 m walk tests. Rater agreement was good for the modified nine-hole peg test: intra-class coefficient r = 0.75 for 
intra-rater reliability and 0.76 for inter-rater reliability. The timed up and go and the 10 m walk tests correlated highly with 
perceived mobility challenges in the quality-of-life questionnaire.
Conclusion: The functional reach, timed up and go and 10 m walk tests are potentially useful outcome measures for 
monitoring neurofibromatosis 1 treatment and will be assessed in multi-centre and longitudinal studies.
Keywords
Neurofibromatosis 1, outcome measure, rater reliability, standard error measurement, minimal detectable change
Date received: 7 December 2017; accepted: 5 June 2018
1 National Centre for Neurofibromatosis, Guy’s Hospital, Guy’s and St 
Thomas’ NHS Foundation Trust, London, UK
2 Department of Physiotherapy, Guy’s and St Thomas’ NHS Foundation 
Trust, London, UK
3Department of Psychology, University of Westminster, London, UK
Corresponding author:
Rebecca L Mullin, National Centre for Neurofibromatosis, Guy’s Hospital, 
Guy’s and St Thomas’ NHS Foundation Trust, Great Maze Pond, London 
SE1 9RT, UK. 
Email: Rebecca.mullin@gstt.nhs.uk
786860 SMO0010.1177/2050312118786860SAGE Open MedicineMullin et al.
research-article2018
Original Article
2 SAGE Open Medicine
reliability within the target population, as variability within a 
disease strongly influences outcome measurement results.3
Inter-rater reliability requires the same group of subjects to 
be measured at the same time by different observers, and intra-
rater reliability considers the same subjects and the same 
observer with measurements taken at different time points.5 
Absolute reliability is expressed as the standard error of meas-
urement (SEM) and this can be calculated from rater reliabil-
ity. Minimal detectable change (MDC) describes the minimal 
amount of change in the instrument score to be sure that the 
score change is not attributable to measurement error. This 
may be calculated from SEM.6
The INF1-QOL questionnaire (impact of NF1 on quality-
of-life questionnaire) is a validated, reliable disease-specific 
questionnaire.2 Responders categorise problems as no issues, 
mild, moderate or severe, in the 14-item, self-report, quality-
of-life questionnaire. It includes two functional domains: 
walking and using the hands.
Advances in molecular biology have facilitated the devel-
opment of novel therapy to include drugs that have the 
potential to treat symptomatic neurofibromas which has 
accelerated the quest for functional outcome measures. The 
primary aim of this study was to evaluate inter- and intra-
rater reliability of four commonly used gait, balance and 
hand function outcome measures in adults with NF1. From 
these data, we calculated the SEM and MDC. The secondary 
aim of this study was to correlate patients’ perceived mobil-
ity and upper limb function as rated through the INF1-QOL 
questionnaire with their objective functional outcome meas-
urement scores.
Methods
Guy’s and St. Thomas’ NHS Foundation Trust is a national 
centre for the diagnosis, management and support of 1150 
people with NF1.
All adults (aged 16 years and over) with NF1 who attended 
their clinic appointments during the 4-month recruitment 
period (May–September 2015) were approached by letter 
inviting them to take part in this observational study. We 
aimed to recruit 50 participants as recommended for a relia-
bility study.3 At the time of their appointment, the treating 
clinician (doctor or nurse) confirmed they met the inclusion/
exclusion criteria and ascertained whether they wished to 
take part or not.
To be included in this study, the participants needed to 
meet the following requirements: have a clinical diagnosis of 
NF1, be aged 16 years or over, have sufficient cognition to 
provide informed consent, not have significant mobility or 
balance impairments that are unrelated to their NF1 and be 
able to walk more than 10 m without physical assistance 
(may use walking aids).
Written consent was collected by the researcher and the 
participant was given a unique alphanumeric research identifi-
cation code. Participants provided demographic information 
and completed a NF1 quality-of-life patient-reported outcome 
measure (INF1-QOL). Each participant completed three rep-
etitions of each of the chosen outcome measures while being 
video recorded or photographed by the researcher.
Ethical permission was granted by National Research 
Ethics Service- Hampstead, reference 15/LO/1084.
Outcome measurement selection
A review of the evidence base identified that a wide variety 
of motor performance outcome measures have undergone 
metric evaluation in comparable cohorts such as chronic 
pain, community dwelling older adults with multi-morbidity, 
spinal cord injury, stroke and multiple sclerosis (MS). The 
research team chose to evaluate motor performance outcome 
measures for walking, balance and use of the hands, based 
on the functional challenges identified by people who have 
NF1 in a pre-study focus group and functional challenges 
identified in the INFI-QOL questionnaire.2 The four selected 
outcome measures were chosen based on a high rate of rater 
reliability in comparable conditions, and following commu-
nication with clinicians and researchers in this field, who 
specified that the outcome measurements needed to be quick 
and easy to perform and interpret in the outpatient clinic 
environment to ensure long-term uptake into practice.
The functional reach test assesses standing balance. In the 
functional reach test,7 the participant stands parallel to a wall 
with arms at 90° of shoulder flexion and reaches forward as 
far as they can without taking a step. A photograph was taken 
at the furthest point that the participant was able to reach and 
measurements are recorded to 1 mm.
The timed up and go test assesses functional mobility. In 
the timed up and go test,8 participants stand from a chair, 
walk 3 m, turn around and return to the chair. Measurements 
are recorded to milliseconds.
The 10 m walk test assesses functional mobility and gait 
speed. In the 10 m walk test,9 participants walk at their nor-
mal speed along a measured walkway. Measurements are 
recorded to milliseconds.
The modified nine-hole peg test assesses upper limb func-
tion through dexterity. In the modified nine-hole peg test, the 
participant takes pegs from a bowl and places them into the 
holes of a peg board. Measurements are recorded to millisec-
onds on a digital stopwatch.
Rating process
Video recordings and photographs of participants perform-
ing the outcome measurement tests were immediately trans-
ferred to a secure electronic location. Four raters watched 
and rated the videos and photographs separately to assess 
inter-rater reliability and they posted their scores for each 
test into a sealed box. One of the raters rated the photographs 
and video recordings a second time, to assess intra-rater reli-
ability. The rater team comprises four experienced members 
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of the NF1 multi-disciplinary team including doctors, a nurse 
and a physiotherapist. The researcher collated these data 
onto a spreadsheet. Data were transferred to SPSS for statis-
tical analysis (Figure 1).
Bias
Several steps were taken to counter bias in this study. The 
researcher was not involved in the recruitment process or as 
a video rater to reduce the risk of researcher bias such as 
selection bias. The intra-rater reliability tester was instructed 
to watch the videos a second time, only after they had 
watched all 49 sets of the videos through once to ameliorate 
recall bias. Outcome measurements were completed with the 
same researcher (R.M.) with standardised instructions to 
reduce the risk of performance bias. Videos were taken of the 
outcome measurement sessions and used for analysis to 
ensure all raters saw the same test after being provided with 
training on how to interpret findings to reduce the risk of 
detection bias.
Statistical analysis
Data from all measures were analysed using the IBM statistical 
package for social sciences (SPSS) version 23. A two-way 
mixed effects model was used to calculate intra-class coeffi-
cient (ICC 3,1) and evaluate relative intra-rater reliability of the 
10 m walk test, timed up and go test, functional reach test and 
nine-hole peg test. A two-way random-effects model was used 
(ICC 2,1) to evaluate inter-rater reliability of the 10 m walk 
test, functional reach test, timed up and go and nine-hole peg 
test (see Table 2). The statistical analysis processes align with 
other studies investigating inter- and intra-rater reliability of 
the selected functional outcome measures.10–12
The ICC is a number between 0 and 1: 1 represents per-
fect reliability with no measurement error and 0 represents 
no reliability. Values less than 0.5 are indicative of poor reli-
ability, values between 0.5 and 0.75 indicate moderate relia-
bility, values between 0.75 and 0.9 indicate good reliability, 
and values greater than 0.90 indicate excellent reliability.13
The SEM, absolute inter- and intra-rater reliability, was 
calculated for each measure in adults with NF1 with the fol-
lowing equation
SEM SD 1 r= −
MDC was calculated for each measure from the SEM 
using the following equation
MDC SEM 1.96 2= × ×
where MDC is the minimal detectable change, SEM is the 
standard error of measurement and r is the reliability (ICC).
Results
A total of 85 adults with NF1 were sent invitation letters for 
this study: 15 did not wish to take part, 14 did not meet the 
eligibility criteria and 7 had not received the participant 
information sheet before their appointment (more than 24 h). 
Thus, 49 ambulant adults with NF1 volunteered and partici-
pated in the study.
There were 29 females and 20 males in this study with a 
mean age of 31 years (range: 16–66 years). The range of 
scores for the INF1-QOL was 1–26, mean score was 9 (where 
0 indicates no difficulty and 42 indicates severe difficulty in 
all 14 domains).
Figure 1. Study flow diagram.
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Table 1 details the ICC for intra-rater and inter-rater reli-
ability for each of the four outcome measurements with 95% 
confidence intervals (95% CI). Reliability (ICC) was excel-
lent with low measurement error and tight 95% CIs for the 
functional reach, timed up and go and 10 m walk test time 
and speed. The modified nine-hole peg test had lower ICCs 
and wider 95% CI than the other three measures. For each 
outcome measure, ICC and 95% CI values were comparable 
for inter- and intra-rater reliability.
Table 2 details the mean score and range for each of the 
above tests alongside clinically important MDC. There was 
a more or less continuous distribution for all measures. The 
wide range of times was not simply due to outliers but 
reflected the clinical heterogeneity of NF1.
Table 3 details the correlations between each functional 
outcome measure and the INF1-QOL questionnaire which 
measured patient reported, disease-specific quality of life. 
Pearson correlations were computed between each func-
tional test and the total INF1-QOL questionnaire scores, sub-
sections for question 7 for walking and question 8 for hand 
function. As can be seen, all functional tests correlated sig-
nificantly with the INF1-QOL total score. For question 7 
‘walking’, the best correlations were for the two measures of 
mobility. By contrast, the correlations with question 8 ‘hand 
function’, were largely non-significant.
Discussion
In this study, we evaluated the inter- and intra-rater reliabil-
ity of a set of functional outcome measures in 49 adults with 
NF1 who were representative of the typical ranges of disease 
severity seen in a published study of quality of life in adults 
with NF1.2 The functional reach test, timed up and go test 
and 10 m walk tests demonstrated excellent reliability for 
both inter- and intra-rater reliability. Interestingly, the modi-
fied nine-hole peg test demonstrated lower inter- and intra-
rater reliability than the other measures tested.
The reliability scores (ICC) for inter- and intra-rater reli-
ability of the functional reach test were excellent. They align 
with high levels of inter- and intra-rater reliability for nor-
mal14 and frail elderly adults.15 The SEM calculated from 
these findings was similar to multiple different clinical popu-
lations, with published standard errors in measurement 
between 1.86 and 2.91 cm for spinal cord injuries,16 stroke11 
and peripheral vestibular disorders.17 The MDC for this 
measure was variable between different clinical populations: 
from 5 cm in spinal cord injury patients to 11.5 cm in 
Parkinson’s.18,19 Relative to the mean functional reach score, 
an MDC of 8.08 cm in NF1 was deemed acceptable.
Inter- and intra-rater reliability scores for the timed up 
and go test were also excellent. They align with high levels 
of inter- and intra-rater reliability for healthy, normal older 
adults.20 There are no published data on SEM or MDC for 
the timed up and go test so currently, it is not possible to 
compare our findings against other clinical groups. Both 
SEM and MDC scores were deemed acceptable in NF1.
Inter- and intra-rater reliability scores for the 10 m walk 
test were also excellent. They align with healthy adults, spi-
nal cord injuries, stroke and traumatic brain injuries with 
ICC greater than 0.9.21–24 The SEM aligns with comparable 
clinical populations including spinal cord injuries,16 
strokes11 and geriatrics.25 An MDC of 0.26 m/s is similar to 
MDC scores for similar clinical populations.
The reliability scores (ICC) for the modified nine-hole 
peg test were 0.75 and 0.76 for intra-rater and inter-rater reli-
ability, respectively. This is lower than the classic nine-hole 
Table 1. Rater reliability: intra-class coefficient (ICC) scores with 95% confidence intervals (95% CI) for outcome measures.
Functional test Intra-rater reliability Inter-rater reliability
ICC 95% CI ICC 95% CI
Functional reach 0.90 0.86, 0.94 0.90 0.87, 0.94
Timed up and go 0.97 0.96, 0.98 0.97 0.96, 0.98
10 m walk 0.99 0.98, 0.99 0.95 0.93, 0.97
10 m walk speed 0.99 0.98, 0.99 0.96 0.94, 0.96
Modified nine-hole peg test 0.75 0.67, 0.83 0.76 0.69, 0.84
Table 2. Mean scores for each outcome measure with standard deviation, range, SEM and MDC scores, calculated from inter-rater 
reliability.
Functional test Mean score 1 Standard deviation Range (min–max) SEM MDC
Functional reach (cm) 31.98 9.68 4.00–38.43 2.92 cm 8.08 cm
Timed up and go (s) 11.63 7.94 5.5–49.82 1.03 s 2.86 s
10 m walk time (s) 6.73 3.80 3.76–26.23 0.87 s 2.40 s
10 m walk speed (m/s) 1.70 0.45 0.39–2.62 0.09 m/s 0.26 m/s
Modified nine-hole peg test (s) 18.36 5.10 11.47–53.62 2.79 s 7.73 s
SEM:  standard error of measurement; MDC: minimal detectable change.
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peg test26 when used in healthy adults and in multiple sclero-
sis, where reliability scores were greater than 0.9.27,28 We 
cannot ignore that this may be because we used a modified 
version of the test, but based on rater feedback we suggest 
that this test may be difficult for people with NF1 because 
the test requires sustained concentration. Individuals with 
NF1 often have cognitive impairment including difficulty 
with concentration and planning meaning that the start and 
end points of the test were difficult to determine because 
some participants hesitated before continuing the task. There 
may also be a muscle force component.29
High levels of rater reliability indicate consistency in 
interpretation, within rater and between raters. MDC scores 
calculated from data collected within this study provide the 
clinician with an important marker that may assist with their 
decision-making. The next stage of metric evaluation of 
these outcome measures, test–retest reliability, will reveal 
how stable the measures are over a time period where NF1 
symptoms remain stable.
There was an overall correlation between the functional 
outcome measurement scores with the total score for the 
quality-of-life questionnaire (INF1-QOL), but greater corre-
lations with sub-items. The highest level of correlation was 
between the mobility outcome measures (timed up and go 
and 10 m walk test) and question 7 of the INF1-QOL meas-
ure which related to walking. The functional reach test is less 
closely aligned with any questions in the INF1-QOL ques-
tionnaire but still achieves statistical significance (–0.47). 
This may be because the functional reach specifically evalu-
ates standing balance, a factor not specifically targeted 
within the INF1-QOL questionnaire. As balance and falls 
were raised as an important concern for people with NF1 in 
the pre-study focus group, this measure may still be of ben-
efit and deserves further exploration as part of future trials. 
Interestingly, there was a small but significant correlation 
(–0.48) between the modified nine-hole peg test and ques-
tion 8 of the INF1-QOL measure which relates to hand func-
tion. As cognitive processing contributes to the time taken to 
perform this test and rater reliability is not as good as the 
other measures, it does not appear to be as useful an outcome 
measure for assessing upper limb function in this patient 
group and measures such as grip dynamometry may be more 
appropriate.
Limitations of study
To our knowledge, this is the first study to evaluate reliabil-
ity of functional outcome measures through use of videos. 
By video recording and photographing participants, we 
could be certain that all raters analysed the same test, from 
the same angle and it also ensured that the researcher could 
continue to stand close to the participant for balance and 
mobility testing and ensure safety as per routine clinical 
practice. We acknowledge that outcome measurement 
assessments are not normally conducted through video 
media but this testing regime was acceptable to participants 
and the research team who needed to fulfil research duties 
around their clinical commitments. We chose to evaluate 
reliability of outcome measures across a variety of profes-
sions (doctors, physiotherapists, nurses) to ensure that raters 
represented the multi-disciplinary team. We were limited by 
the time available to carry out the study but as outlined, this 
did not impact on the value of our data. Assessment of other 
upper limb outcome measures would have proved fruitful 
and this will be the focus of future work.
Originally we aimed to recruit 50 individuals for the 
study, but achieved 49 participants. Although this might 
appear to be a limitation, in practical terms it did not alter the 
reliability estimates. This is because the reliabilities that we 
observed were predominantly 0.9 or better apart from the 
modified nine-hole peg test which was 0.75–0.76. Indeed, 
Shoukri et al.30 demonstrate that sample size theory demon-
strates that our study is adequately powered for reliabilities 
in the range observed in our study.30 Many reliability studies, 
using similar methods, have employed as few as 16 partici-
pants to evaluate reliability.12
Conclusion
There is a need for reliable functional outcome measures to 
monitor treatment and to evaluate novel therapy in NF1 
adults. The functional reach, timed up and go and 10 m walk 
tests had excellent inter- and intra-rater reliability and were 
quick and easy to perform in a clinic setting. Furthermore, 
these tests correlated highly with perceived functional chal-
lenges of mobility in the INF1-QOL questionnaire. The 
modified nine-hole peg test was slightly less reliable and 
Table 3. Correlation Pearson (r) between each functional test and subsections of the INF1-QOL questionnaire with significance level.
Functional test Correlation with 
questionnaire total score, r
Correlation with question 
7 walking, r
Correlation with question 
8 hand function, r
Functional reach (cm) −0.32* −0.47** −0.19 ns
Timed up and go (s) 0.43** 0.71** 0.25 ns
10 m walk time (s) 0.42** 0.73** 0.18 ns
10 m walk speed (m/s) −0.51** −0.71** −0.23 ns
Modified nine-hole peg test (s) 0.36* 0.48** 0.32*
ns: not significant.
*p < 0.05; **p < 0.01.
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other upper limb measures such as dynamometry should be 
evaluated in this group of patients. Our future aims will be to 
evaluate these motor outcome measures in multi-centre and 
longitudinal studies. We will also use them as tools for 
assessing patient outcome of therapeutic interventions.
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